Peer Review History
| Original SubmissionAugust 27, 2023 |
|---|
|
PONE-D-23-27587The proliferation of antibiotic resistance genes (ARGs) and microbial communities in industrial wastewater treatment plant treating N,N-dimethylformamide (DMF) by AAO processPLOS ONE Dear Dr. Gao, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Catarina Leite Amorim, Ph.D. Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. In your Methods section, please provide additional information regarding the permits you obtained for the work. Please ensure you have included the full name of the authority that approved the field site access and, if no permits were required, a brief statement explaining why. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “We thank the financial supported by the Open Project of Engineering Research Center of Bio film Water Purification and Utilization Technology of Ministry of Education (BWPU2021ZY02) and Outstanding Innovative Research Team for Molecular Enzymology and Detection in Anhui Provincial Universities (2022AH010012)” We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “The author(s) received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. Please upload a copy of Supporting Information Table S1 which you refer to in your text on page 3. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This work uses a very powerful tool to analyze all the resistome in environment samples. The rationale to support analyzing a WWPT degrading the DMF is weak, and the discussion of the results is superficial. The methodology is very general, and many details are missing. Define AAO acronym in the abstract Introduction May the Authors support the statements about introduced bacteria? “it is common to introduce these bacteria into WWPTs to degrade the DMF.” Or “However, the introduced bacteria may be the major driver impacting the ARGs profile. Although the biological treatment could reduce DMF significantly, the abundance of ARGs in the effluents may be high. and effluents may favor the persistence and spread of antibiotic resistance in the microbial communities of the receiving environments.” The introduction may be more supportive of the relevance of analyzing ARGs in a DMF containing wastewater. Why could this chemical be relevant to ARG or their transferring in the microbial community? The introduction and final paragraph seem to be a summary of the methodology and results. In the authors’ guidelines, only a conclusive brief statement is required. Please be more specific. Methodology Could the authors may be specific about their “samples replicates”?. Do sampling was carried out on different days? Please specify Line 106. Please justify “The abundance of expressed ARGs”, if the analysis was DNA-based, authors can’t claim “gene expression”. In the same sense, lines 120, 129 mention transcripts. Is it correct? The methodology for DMF analysis is missing. Table S1 is missing. Results How the 16S rRNA Absolute gene abundance was quantified? This methodology is missing. How do the authors explain a higher abundance in the effluent (Fig 1c)? The authors may explain better the process in the WWTP and their conditions? Does the WWTP have a settling unit for aerobic flocs? The units of 16S rRNA concentration in Figure 1c are missing. Line 157. Why the different IN clustering was so “obviously”? Define the MGE acronym. The authors may support this discussion with a deep literature review: “We infer that the increase abundance of ARGs in WWTPs may be related to bacterium community, because many previous studies have demonstrated that some phylum of strain was closely related to the enrichment of ARGs.” Figure 2E, is lacking the label corresponding to each pie chart. How did the authors select the pathogenic bacteria from the whole bacteria community? This methodology is unclear. The authors may justify this statement “Specifically, DMF had a significant positive correlation with Bacillus, which was belonging to Firmicutes, indicated that DMF may promote the growth of Bacillus. Furthermore”. A positive correlation doesn’t mean a biological activity. This is the only discussion about the effect of DMF.. So, it seems irrelevant to the study, which contradicts the justification in the introduction. Authors may reconsider if DMF can be a determinant parameter to study. Reviewer #2: 1 First person must not be used in the manuscript, such as our, we. 2 In Abstract, the DMF should be first given the complete name, not only abbreviation. 3 the keywords were not approviate, DMF should be included. 4 The instrument of HT-qPCR should be given. 5 The gene name should be italic. 6 The ARGs should be analyzed by different category. 7 The component of wastewater have an effect on abundance of ARGs this sentence should be changed, for “have an effect” was nonsense. 8 The effect of DMF should be focused. 9 The effect of MGEs should be focused. Reviewer #3: In this study, wastewater from five stages of the AAO process at a designated water plant was collected and analyzed for COD, DMF, ARGs, and microbial community structure. Results showed that the AAO process may act as a microbial source that increases the total abundance of ARGs, and the wastewater had higher abundance of ARGs for non-pathogenic bacteria than for pathogenic bacteria. Overall, this study provides information on microbial community structure and the mechanisms driving changes in the abundance of ARGs in industrial wastewater treatment plants. However, before considering publication, the following questions should be addressed. My specific comments are as follows: 1. Authors should be aware of spelling and formatting errors, eg. line 67. 2. This study sampled only one specific water plant which is not representative and the conclusions may not be generalizable. The authors should add some related references for comparison such as Journal of Environmental Management,Volume 347, 2023, 119053, Journal of Hazardous Materials,Volume 298, 2015, Pages 303-309, Process Safety and Environmental Protection,Volume 93, 2015, Pages 68-74. 3. COD was consistent with the amount of DMF. A correlation chart is suggested to add to make it clear. 4. Abbreviations need to be spelled out in full the first time they appear, DMF,AAO in the abstract, PCA in the methodology on line 31.MGEs in the result. 5. In the conclusion, it is stated that the DMFs in Figure 2b for AP, ANP, AEP, but the graph shows significantly higher values for AP than for influent and effluent.Please check it. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-23-27587R1The proliferation of antibiotic resistance genes (ARGs) and microbial communities in industrial wastewater treatment plant treating N,N-dimethylformamide (DMF) by AAO processPLOS ONE Dear Dr. Gao, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Catarina Leite Amorim, Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) Reviewer #4: This article presents a comprehensive analysis of the presence and distribution of Antibiotic Resistance Genes (ARGs) in industrial wastewater treatment plants (WWTPs). It successfully addresses a significant gap in the literature by focusing on industrial WWTPs, a subject that is largely overlooked in favor of studies on hospital and urban WWTPs. The methodology employed in the study, which includes the collection of 15 wastewater samples from five stages of the anaerobic anoxic aerobic (AAO) process, is robust and lends credibility to the findings. The article is well-structured and logically organized, with each step of the research process clearly delineated. It does an excellent job of presenting complex scientific data in a readable and understandable format. The findings are clearly articulated, and the use of graphs and tables to depict data enhances readability and understanding. The study's findings are significant and troubling, revealing a clear increase in ARGs in effluents of biological treatments and suggesting that the AAO process may serve as a microbial source, increasing ARGs' total abundance. The article also provides an intriguing insight into the connection between the structure of bacterial communities and the dynamics of ARGs. Overall, this is an excellent and timely piece of research that contributes significantly to our understanding of ARGs in industrial WWTPs. It is well-executed, thorough, and provides a strong foundation for future research in this area. The results of the study are quite comprehensive and detailed. However, there are several areas that could benefit from some fine-tuning and adjustments. I think that the paper is publishable in the journal after some minor revision. See my specific comments below: 1. Providing a graphical abstract can aid readers in better understanding the article. 2. The current text seems to include conclusions within the results section. Typically, it is best to keep these sections separate, with the results section strictly presenting the findings, and interpretation or implications discussed in the conclusion section. 3. There are several typos or grammatical errors that need to be corrected. 4. The writing style is quite passive. In scientific writing, active voice is often preferred as it is more direct and concise. 5. Line 106, "The wastewater was collected from the Shen Nuobei industrial wastewater treatment plant (118.507° N, 31.689° E),Ma’anshan city, Anhui province, China, in December 2021.", suggest to change to "In December 2021, wastewater was sampled from the Shen Nuobei industrial wastewater treatment plant located in Ma'anshan city, Anhui province, China (118.507° N, 31.689° E)." 6. Line 110, "Collected 2 L of wastewater samples from influent, anaerobic, anoxic, aerobic, and effluent tanks.", suggest to change to "Two liters of wastewater samples were collected from the influent, anaerobic, anoxic, aerobic, and effluent tanks." 7. Line 111, "Repeat sampling of each sample three times at different locations at the same time.", suggest to change to "Each sample was collected three times from different locations concurrently." 8. Line 301, "ARGs has increased rapidly" should be changed to "ARGs have increased rapidly". 9. Line 303, "a previous research" should be changed to "previous research". 10. Line 305, "lead to a significant increase" should be changed to "leading to a significant increase". 11. Line 341, "withour" should be corrected to "with our". 12. Line 380, "the horizontal gene transfer via natural transformation between nonpathogen is still high" should be changed to "the horizontal gene transfer via natural transformation among non-pathogens remains high". 13. Line 382, "implementing measure" should be changed to "implementing measures". ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
The proliferation of antibiotic resistance genes (ARGs) and microbial communities in industrial wastewater treatment plant treating N,N-dimethylformamide (DMF) by AAO process PONE-D-23-27587R2 Dear Dr. Gao, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Catarina Leite Amorim, Ph.D. Academic Editor PLOS ONE -------------------------------------- Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #4: The authors have revised the paper carefully according to the comments, and addressed all the comments raised by me, I think the revised paper can be accepted for publication in its present form now. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-23-27587R2 PLOS ONE Dear Dr. Gao, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Catarina Leite Amorim Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .